United Therapeutics Chairperson, CEO Martine Rothblatt disposes of USD 4.88 million in common shares

• United Therapeutics Chairperson and CEO Martine A. Rothblatt exercised stock options for 9,500 shares at USD 117.76 on Oct. 7, 2026.
• Family trust sales totaled 9,500 shares on Oct. 7 at weighted-average prices from USD 542.7339 to USD 556.4848.
• Trust holdings ended at 324,443 shares following the transactions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. United Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001106578-26-000159), on October 08, 2026, and is solely responsible for the information contained therein.